Remission roles of the herbal formula B401 in mice with manganese-induced neurotoxicity

References

• Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol. 1837;1:41–42.
   Google Scholar
• Huang CC, Chu NS, Lu CS, et al. Chronic manganese intoxication. Arch Neurol. 1989;46(10):1104–1106.
   PubMed Web of Science ®Google Scholar
• Kawamura R, Ikuta H, Fukuzumi S, Yamada R, Tsubaki S, Kodama T, Kurata S. Intoxication by manganese in well water. Kitasato Arch Exp Med. 1941;18:145–169.
   Google Scholar
• Mergler D, Huel G, Bowler R, et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res. 1994;64(2):151–180.
   PubMed Web of Science ®Google Scholar
• Hauser RA, Zesiewicz TA, Rosemurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol. 1994;36(6):871–875.
   Web of Science ®Google Scholar
• Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet. 1995;346(8970):270–274.
   PubMed Web of Science ®Google Scholar
• Calne DB, Chu NS, Hung CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology. 1999;44(9):1583–1586.
   Google Scholar
• Olanow CW. Manganese-induced parkinsonism and Parkinson’s disease. Ann N Y Acad Sci. 2004;1012:209–223.
   PubMed Web of Science ®Google Scholar
• Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicity. 1999;20(2–3):227–238.
   PubMed Web of Science ®Google Scholar
• Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci. 1973;20(4):415–455.
   PubMed Web of Science ®Google Scholar
• Eriksson H, Magiste K, Olantin LO, et al. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch Toxicol. 1987;61:46–52.
   PubMed Web of Science ®Google Scholar
• Yamada M, Ohno S, Okayasu I, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. 1986;70(3–4):273–278.
   PubMed Web of Science ®Google Scholar
• Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC. Modification of chronic manganese poisoning. N Engl J Med. 1970;282(1):5–10.
   PubMed Web of Science ®Google Scholar
• Brouillet EPL, Shinobu U, McGarvey F, et al. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol. 1993;120(1):89–94.
   PubMed Web of Science ®Google Scholar
• Maynard LS, Cotzias GC. The partition of manganese among organs, and intracellular organelles of the rat. J Biochem Chem. 1955;214(1):489–495.
   Google Scholar
• Wang SE, Lin CL, Hsu CH, Sheu SJ, Chien CT, Wu CH. Treatment of a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s disease. Drug Des Devel Ther. 2015;9:887–900.
   Web of Science ®Google Scholar
• Wang SE, Lin CL, Hsu CH, Sheu SJ, Wu CH. Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice. Clin Interv Aging. 2015;10:1825–1837.
   Web of Science ®Google Scholar
• Hsu CH, Lin CL, Wang SE, Sheu SJ, Chien CT, Wu CH. Oral treatment of a herbal formula B401 alleviates penile toxicity for aging mice with manganism via enhancing synthesis of nitric oxide and angiogenesis, and suppressing oxidative stress, inflammation and apotosis. Clin Interv Aging. 2015;10:1173–1187.
   Web of Science ®Google Scholar
• Lazrishvili IL, Shukakidze AA, Chkhartishvili NN, Bikashvili TZ. Morphological changes and manganese content in the brains of rat pups subjected to subchronic poisoning with manganese chloride. Neurosci Behav Physiol. 2009;39(1):7–12.
   PubMedGoogle Scholar
• Cordova FM, Aguiar AS Jr, Peres TV, et al. Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox. Arch Toxicol. 2013;87(7):1231–1244.
   PubMed Web of Science ®Google Scholar
• Keen CL, Ensunsa JL, Clegg MS. Manganese metabolism in animals and humans including the toxicity of manganese. Metal Ions Biol. 2000;37:89–121.
   PubMedGoogle Scholar
• Mergler D, Huel G, Bowler R, et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res. 1994;64(2):151–180.
   PubMed Web of Science ®Google Scholar
• Roth JA. Are there common biochemical and molecular mechanisms controlling manganism and parkinsonism. Neuromolecular Med. 2009;11(4):281–296.
   PubMed Web of Science ®Google Scholar
• Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. 2011;134(Pt 11):3146–3166.
   Google Scholar
• Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA. Reduced BDNF mRNA expression in the Parkinson’s disease substantia nigra. Exp Neurol. 2000;166(1):127–135.
   PubMed Web of Science ®Google Scholar
• Cordova FM, Aguiar AS Jr, Peres TV, et al. In vivo manganese exposure modulates erk, akt and darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS ONE. 2012;7(3):e33057.
   Web of Science ®Google Scholar
• Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o’-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson’s disease. J Biol Chem. 1999;274(49):34621–34628.
   Web of Science ®Google Scholar
• Tamm C, Sabri F, Ceccatelli S. Mitochondrial-mediated apoptosis in neural stem cells exposed to manganese. Toxicol Sci. 2008;101(2):310–320.
   Web of Science ®Google Scholar
• Yin Z, Aschner JL, dos Santos AP, Aschner M. Mitochondrial dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res. 2008;1203:1–11.
   PubMed Web of Science ®Google Scholar
• Zhang F, Xu Z, Gao J, Xu B, Deng Y. In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol. 2008;26(2):232–236.
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol. 2005;75(3):207–246.
   PubMed Web of Science ®Google Scholar
• Tatton WG, Chalmers-Redman R, Brown D, Tatton N, Apoptosis in Parkinson’s disease: signals for neuronal degradation. Ann Neurol. 2003;53(Suppl 3):S61–S70.
   Google Scholar
• Hartmann A, Hunot S, Michel PP, et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease. Proc Natl Acad Sci U S A. 2000;97(6):2875–2880.
   PubMed Web of Science ®Google Scholar
• Chen XC, Zhu YG, Zhu LA, et al. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol. 2003;473(1):1–7.
   PubMed Web of Science ®Google Scholar
• Yu S, Li S, Yang H, Lee F, Wu JT, Qian MG. A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. Rapid Commun Mass Spectrom. 2005;19(2):250–254.
   PubMed Web of Science ®Google Scholar